Financials

  • Market Capitalization 405.51 M
  • Employee 45
  • Founded 2019
  • CEO N/A
  • Website www.x4pharma.com
  • Headquarter Delaware, United States
  • FIGI BBG001J1CYH8
  • Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
3.68
市销率
35.88

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
3030
RCKT
Rocket Pharmaceuticals, Inc. - Common Stock
3.80 USD+2.15%+0.80%+21.41%+16.21%417.14 M USD
3031
CMPX
Compass Therapeutics, Inc. - Common Stock
2.31 USD-3.35%-8.70%+19.07%-33.04%416.00 M USD
3051
LRMR
Larimar Therapeutics, Inc. - Common Stock
3.89 USD+1.83%-6.27%+1.57%+6.28%404.10 M USD
3085
ENTA
Enanta Pharmaceuticals, Inc. - Common Stock
13.40 USD+0.53%-6.62%+5.51%+54.02%390.28 M USD

新闻